|
|
Relief Therapeutics Holding SA
/ Key words: Conference
Relief Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
07.09.2022 / 07:00 CET/CEST
Relief Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
Geneva, Switzerland, September 7... Lire le communiqué |
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: Miscellaneous
Relief Therapeutics files registration statement on form F1 with the U.S. Securities and Exchange Commission
24Aug2022 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
RELIEF THERAP... Lire le communiqué |
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: Legal Matter
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. announce tentative settlement of pending litigation
22Aug2022 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
RELIEF THERAPEUTICS H... Lire le communiqué |
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: Personnel
Relief Therapeutics Appoints David McCullough as Head of U.S. Market Access
17Aug2022 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
Relief Therapeutics Appoints David McCullough as Head of U... Lire le communiqué |
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: Regulatory Admission
Relief Therapeutics and Acer Therapeutics Announce that the European Commission Has Granted Orphan Drug Designation for ACER001 in Maple Syrup Urine Disease
12Aug2022 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement... Lire le communiqué |
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: Research Update
Relief Therapeutics Announces Promising Initial Stability Data on a New Formulation of RLF100® Aviptadil
03Aug2022 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
Relief T... Lire le communiqué |
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: Regulatory Admission
Acer Therapeutics and Relief Therapeutics Announce ACER001 IND Submission for the Treatment of Maple Syrup Urine Disease
28Jul2022 / 07:05 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
A... Lire le communiqué |
|
| |
|
| |
